Trump Administration Proposes Rule to Lower Medicare Drug Prices

The Trump administration proposed a new rule on Thursday intended to prevent hospitals from adding markups to discounted drugs for Medicare patients. According to administration estimates, the measure could save consumers $1.1 billion next year.

The rule would apply to hospitals serving low-income patients through the 340B program, which allows them to purchase outpatient prescription drugs at discounted prices. Under the current system, hospitals can bill insurers at higher rates than their acquisition costs, retaining the difference, which leads to increased patient expenses.

The proposed regulation would modify the reimbursement formula used by the Centers for Medicare & Medicaid Services (CMS) for participating hospitals, aiming to reduce patient out-of-pocket costs.

During an election year, the administration has sought to demonstrate action on healthcare affordability for American families facing rising costs. While several cost-saving measures have been introduced, the ultimate impact of these initiatives on overall healthcare spending remains uncertain due to the system's complexity.